Search
Careers
Contact
About Us
About Sosei Heptares
Corporate Details
Mission, Vision, Values
Celebrating 30 Years
Our Leadership
Board of Directors
Executive Officers
Locations
Global Policies
Disclosure Policy
Social Media Policy
Privacy Notice
Cookie Policy
Laboratory Animal Care Policy
Whistleblowing Policy
Our Science
Our Science
What are GPCRs
Proprietary Research Platform
Intellectual Property
Scientific Advisory Board
Clinical Data and Presentations
Science Center - CHISHIKI
Other Programs for Partnering
Our Pipeline
R&D Pipeline
In-house Programs
Partnered Programs
Our Medicines
Ultibro® and Seebri®
Enerzair® Breezhaler®
ORAVI®
PIVLAZ®
Newsroom
Press releases
In the News
Publications
Investors
Financial & IR Information
Presentations and Webcasts
Financial Results
Securities Reports
Annual Report
Financial Highlights
Analyst Coverage
Analyst Report
Stock Information
General Stock Information
Shareholder's Meetings & Publications
Corporate Governance
ESG Report 2022
Corporate Governance Report
Corporate Governance Guidelines
Modern Slavery Statements
Other IR Information
IR Blog (Japanese Only)
Events
Email Alerts
Search
Careers
Contact
About Us
About Sosei Heptares
Corporate Details
Mission, Vision, Values
Celebrating 30 Years
Our Leadership
Board of Directors
Executive Officers
Locations
Global Policies
Disclosure Policy
Social Media Policy
Privacy Notice
Cookie Policy
Laboratory Animal Care Policy
Whistleblowing Policy
Our Science
Our Science
What are GPCRs
Proprietary Research Platform
Intellectual Property
Scientific Advisory Board
Clinical Data and Presentations
Science Center - CHISHIKI
Other Programs for Partnering
Our Pipeline
R&D Pipeline
In-house Programs
Partnered Programs
Our Medicines
Ultibro® and Seebri®
Enerzair® Breezhaler®
ORAVI®
PIVLAZ®
Newsroom
Press releases
In the News
Publications
Investors
Financial & IR Information
Presentations and Webcasts
Financial Results
Securities Reports
Annual Report
Financial Highlights
Analyst Coverage
Analyst Report
Stock Information
General Stock Information
Shareholder's Meetings & Publications
Corporate Governance
ESG Report 2022
Corporate Governance Report
Corporate Governance Guidelines
Modern Slavery Statements
Other IR Information
IR Blog (Japanese Only)
Events
Email Alerts
Careers
Careers
Global jobs portal
What's it like to work here
Join our Talent Community
Search
Careers
Contact
Press release
Press releases
In the News
Publications
Nov 10, 2023
Consolidated Financial Results for the Nine Months Ended September 30, 2023 (IFRS)
Consolidated Financial Results for the Nine Months Ended September 30, 2023(IFRS)
DOWNLOAD PDF
Return
DOWNLOAD PDF